Evidence mapPaperPMID 41909197Full record

ReviewJournal of hepatocellular carcinoma2026

Exosome-Mediated Regulation of Aerobic Glycolysis in Hepatocellular Carcinoma: Mechanisms and Therapeutic Implications.

Ye Zang, Rui Zhao

Abstract readReview
In one paragraph

Review in Journal of hepatocellular carcinoma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ye ZangLanzhou University, Lanzhou, Gansu Province, 730030, People's Republic of China.
Rui ZhaoDepartment of Hepatology, Lanzhou University Second Hospital, Lanzhou, 730030, People's Republic of China.ORCID 0009-0004-2031-5592

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is one of the most common and poor prognosis digestive malignant tumors with high morbidity and mortality worldwide. Aerobic glycolysis, also known as the Warburg effect, is a hallmark of cancer metabolism and plays a pivotal role in the genesis, development, metastasis and drug resistance of HCC. Exosomes are nanoscale membrane vesicles secreted by cells and widely found in various body fluids, capable of carrying a variety of bioactive molecules, such as proteins, nucleic acids, lipids, etc, and mediating intercellular communication. Increasing evidence indicates that exosomes regulate metabolic reprogramming in HCC by transferring specific bioactive molecules or modulating key signaling pathways. Through these mechanisms, exosomes influence the expression and activity of glycolysis-related enzymes, ultimately affecting the proliferation, invasion, migration, and chemosensitivity of HCC cells. This review focuses on the exosome-mediated regulation of aerobic glycolysis in HCC and highlights the therapeutic potential of targeting exosome-mediated metabolic pathways, offering new perspectives for combination treatment strategies in HCC.

Indexed as

aerobic glycolysiscombination therapyexosomeshepatocellular carcinomatumor microenvironment

Identifiers

PMID41909197
PMCPMC13019164

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.